Literature DB >> 9846920

Screening for visual and ocular disorders in children, evaluation of the system in Sweden.

G Kvarnström1, P Jakobsson, G Lennerstrand.   

Abstract

The aim of this study was to evaluate the visual screening system in Sweden. We have made a retrospective investigation of the results of screening for ocular disease and visual impairment of all children born in 1982 in three Swedish communities. The records from screening examinations from 0 to 10 y and from diagnostic follow-up at the departments of ophthalmology that the children were referred to were inspected. The data were used to evaluate the efficiency of the Swedish visual screening system. The study included 3126 children. The attendance rate at the 4-y examination was better than 99%. The sensitivity of the 4- and 5.5-y screening examinations was on the average 92% and the specificity was 97%. The average number of false negative cases at 4 y was 5.6 in 1000 (0.56%). With this screening and subsequent diagnosis and treatment, the prevalence of amblyopia at different levels of visual acuity at the age of 10 y was: 0.06% with visual acuity < or = 0.1, 0.9% with visual acuity < or = 0.5 and 1.7% with visual acuity < or = 0.7. In spite of largely unchanged pressure of amblyogenic factors in the population, the prevalence of deep and moderate amblyopia has been markedly reduced by screening and early treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9846920     DOI: 10.1080/080352598750031176

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  18 in total

1.  Prevalence, causes and associations of amblyopia in year 1 students in Central China : The Anyang childhood eye study (ACES).

Authors:  Jing Fu; Shi Ming Li; Si Yuan Li; Jin Ling Li; He Li; Bi Dan Zhu; Zhou Yang; Lei Li; Ning Li Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-08       Impact factor: 3.117

2.  The prevalence of amblyopia in Germany: data from the prospective, population-based Gutenberg Health Study.

Authors:  Heike M Elflein; Susanne Fresenius; Julia Lamparter; Susanne Pitz; Norbert Pfeiffer; Harald Binder; Philipp Wild; Alireza Mirshahi
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

3.  Ocular manifestations in congenital toxoplasmosis.

Authors:  Laurent Kodjikian; Martine Wallon; Jacques Fleury; Philippe Denis; Christine Binquet; François Peyron; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

Review 4.  Amblyopia: a mini review of the literature.

Authors:  Evgenia Kanonidou
Journal:  Int Ophthalmol       Date:  2011-03-20       Impact factor: 2.031

5.  Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the multi-ethnic pediatric eye disease study.

Authors: 
Journal:  Ophthalmology       Date:  2007-10-22       Impact factor: 12.079

Review 6.  The relationship between anisometropia and amblyopia.

Authors:  Brendan T Barrett; Arthur Bradley; T Rowan Candy
Journal:  Prog Retin Eye Res       Date:  2013-06-15       Impact factor: 21.198

7.  Prevalence of refractive errors among pre-school children at King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Authors:  Mohammad A Al-Rowaily
Journal:  Saudi J Ophthalmol       Date:  2010-04-02

8.  Amblyopia treatment outcomes after screening before or at age 3 years: follow up from randomised trial.

Authors:  C Williams; K Northstone; R A Harrad; J M Sparrow; I Harvey
Journal:  BMJ       Date:  2002-06-29

9.  Prevalence of amblyopia or strabismus in asian and non-Hispanic white preschool children: multi-ethnic pediatric eye disease study.

Authors:  Roberta McKean-Cowdin; Susan A Cotter; Kristina Tarczy-Hornoch; Ge Wen; Jeniffer Kim; Mark Borchert; Rohit Varma
Journal:  Ophthalmology       Date:  2013-05-19       Impact factor: 12.079

10.  Quantitative pediatric vision screening in primary care settings in Alabama.

Authors:  Wendy L Marsh-Tootle; Terry C Wall; John S Tootle; Sharina D Person; Robert E Kristofco
Journal:  Optom Vis Sci       Date:  2008-09       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.